跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Pospenem - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Pospenem
Approved
STANDARD
Pospenem
JW Pharmaceutical Corporation
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
72525ea3af071c38
Company
JW Pharmaceutical Corporation
Type
Standard
Approval Details
Approval Id
72525ea3af071c38
Drug Approval Philippines Name
Pospenem
Product Name
Pospenem
Registration Number
DR-XY44657
Brand Name
Pospenem
Generic Name
Meropenem (as trihydrate)
Dosage Form
Powder for Injection (IV Infusion)
Dosage Strength
1g
Manufacturer
JW Pharmaceutical Corporation
Importer
Medlink Marketing Inc.
Distributor
Medlink Marketing Inc.
Company Detail Path
/organization/jw-pharmaceutical-corporation
Issuance Date
24 January 2025
Expiry Date
23 June 2029
Pharmacologic Category
Antibacterial (Carbapenem)
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
72525ea3af071c38
Type
Standard
Back to Philippines FDA Approvals